HEADER PROTEIN BINDING 30-AUG-19 6SP1 TITLE KEAP1 IN COMPLEX WITH COMPOUND 6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KELCH DOMAIN, RESIDUES 321-609; COMPND 5 SYNONYM: CYTOSOLIC INHIBITOR OF NRF2,INRF2,KELCH-LIKE PROTEIN 19; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KEAP1, INRF2, KIAA0132, KLHL19; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NRF2, KEAP1, PROTEIN-PROTEIN INTERACTIONS, HUNTINGTONS DISEASE, KEYWDS 2 TETRAHYDROISOQUINOLINE, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR J.M.ONTORIA,I.BIANCOFIORE,P.FEZZARDI,E.TORRENTE DE HARO,S.COLARUSSO, AUTHOR 2 E.BIANCHI,M.ANDREINI,A.PATSILINAKOS,V.SUMMA,R.PACIFICI,I.MUNOZ- AUTHOR 3 SANJUAN,L.PARK,A.BRESCIANI,C.DOMINGUEZ,L.TOLEDO-SHERMAN,S.HARPER REVDAT 1 03-JUN-20 6SP1 0 JRNL AUTH J.M.ONTORIA,I.BIANCOFIORE,P.FEZZARDI,F.FERRIGNO,E.TORRENTE, JRNL AUTH 2 S.COLARUSSO,E.BIANCHI,M.ANDREINI,A.PATSILINAKOS,G.KEMPF, JRNL AUTH 3 M.AUGUSTIN,S.STEINBACHER,V.SUMMA,R.PACIFICI,I.MUNOZ-SANJUAN, JRNL AUTH 4 L.PARK,A.BRESCIANI,C.DOMINGUEZ,L.T.SHERMAN,S.HARPER JRNL TITL COMBINED PEPTIDE AND SMALL-MOLECULE APPROACH TOWARD JRNL TITL 2 NONACIDIC THIQ INHIBITORS OF THE KEAP1/NRF2 INTERACTION. JRNL REF ACS MED.CHEM.LETT. V. 11 740 2020 JRNL REFN ISSN 1948-5875 JRNL PMID 32435379 JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00594 REMARK 2 REMARK 2 RESOLUTION. 2.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 102.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 35659 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.500 REMARK 3 FREE R VALUE TEST SET COUNT : 905 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.57 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2593 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.3500 REMARK 3 BIN FREE R VALUE SET COUNT : 45 REMARK 3 BIN FREE R VALUE : 0.4300 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4372 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 97 REMARK 3 SOLVENT ATOMS : 173 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.05 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.42000 REMARK 3 B22 (A**2) : -1.52000 REMARK 3 B33 (A**2) : 1.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.275 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.205 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.152 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.309 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4541 ; 0.008 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 3990 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6177 ; 1.044 ; 1.952 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9171 ; 0.863 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 568 ; 6.404 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 207 ;31.095 ;22.464 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 642 ;10.885 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 42 ;13.770 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 655 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5245 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 991 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 559 ; 0.141 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3910 ; 0.136 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2064 ; 0.153 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2496 ; 0.064 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 168 ; 0.064 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 1 ; 0.051 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 24 ; 0.111 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.085 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 325 A 609 REMARK 3 ORIGIN FOR THE GROUP (A): 0.0000 0.0000 0.0000 REMARK 3 T TENSOR REMARK 3 T11: 0.0709 T22: 0.0188 REMARK 3 T33: 0.1154 T12: 0.0044 REMARK 3 T13: 0.0744 T23: 0.0227 REMARK 3 L TENSOR REMARK 3 L11: 2.2992 L22: 2.8878 REMARK 3 L33: 1.4333 L12: -0.2494 REMARK 3 L13: 0.0561 L23: -0.0027 REMARK 3 S TENSOR REMARK 3 S11: 0.0124 S12: 0.0823 S13: -0.0269 REMARK 3 S21: -0.0567 S22: 0.0052 S23: 0.1424 REMARK 3 S31: 0.1199 S32: -0.1247 S33: -0.0175 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 325 B 609 REMARK 3 ORIGIN FOR THE GROUP (A): 0.0000 0.0000 0.0000 REMARK 3 T TENSOR REMARK 3 T11: 0.0308 T22: 0.1292 REMARK 3 T33: 0.1156 T12: 0.0118 REMARK 3 T13: 0.0272 T23: 0.0902 REMARK 3 L TENSOR REMARK 3 L11: 2.5869 L22: 1.9941 REMARK 3 L33: 1.8213 L12: -0.3082 REMARK 3 L13: 0.0432 L23: 0.0714 REMARK 3 S TENSOR REMARK 3 S11: -0.0911 S12: -0.0451 S13: 0.1169 REMARK 3 S21: 0.1032 S22: 0.0349 S23: -0.0302 REMARK 3 S31: -0.0901 S32: 0.0267 S33: 0.0561 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 6SP1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-AUG-19. REMARK 100 THE DEPOSITION ID IS D_1292104083. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36564 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.570 REMARK 200 RESOLUTION RANGE LOW (A) : 102.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.43600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 14.62 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 73.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM ACETATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.08200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 102.41950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.19350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 102.41950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.08200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.19350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 317 REMARK 465 SER A 318 REMARK 465 HIS A 319 REMARK 465 MET A 320 REMARK 465 ALA A 321 REMARK 465 PRO A 322 REMARK 465 LYS A 323 REMARK 465 VAL A 324 REMARK 465 GLY B 317 REMARK 465 SER B 318 REMARK 465 HIS B 319 REMARK 465 MET B 320 REMARK 465 ALA B 321 REMARK 465 PRO B 322 REMARK 465 LYS B 323 REMARK 465 VAL B 324 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 447 NE CZ NH1 NH2 REMARK 480 GLN A 528 CD OE1 NE2 REMARK 480 LYS A 551 CD CE NZ REMARK 480 ARG B 415 CZ NH1 NH2 REMARK 480 GLU B 446 CD OE1 OE2 REMARK 480 GLN B 528 CG CD OE1 NE2 REMARK 480 LYS B 551 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 335 100.06 -160.10 REMARK 500 ARG A 336 -46.91 71.12 REMARK 500 HIS A 575 -38.98 -135.21 REMARK 500 ARG B 336 -45.71 71.10 REMARK 500 VAL B 453 -169.09 -112.90 REMARK 500 THR B 481 -59.36 -120.28 REMARK 500 HIS B 575 -57.78 -128.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 888 DISTANCE = 6.86 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LQ8 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 706 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 707 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 708 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 709 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 710 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 706 DBREF 6SP1 A 321 609 UNP Q14145 KEAP1_HUMAN 321 609 DBREF 6SP1 B 321 609 UNP Q14145 KEAP1_HUMAN 321 609 SEQADV 6SP1 GLY A 317 UNP Q14145 EXPRESSION TAG SEQADV 6SP1 SER A 318 UNP Q14145 EXPRESSION TAG SEQADV 6SP1 HIS A 319 UNP Q14145 EXPRESSION TAG SEQADV 6SP1 MET A 320 UNP Q14145 EXPRESSION TAG SEQADV 6SP1 ALA A 540 UNP Q14145 GLU 540 CONFLICT SEQADV 6SP1 ALA A 542 UNP Q14145 GLU 542 CONFLICT SEQADV 6SP1 GLY B 317 UNP Q14145 EXPRESSION TAG SEQADV 6SP1 SER B 318 UNP Q14145 EXPRESSION TAG SEQADV 6SP1 HIS B 319 UNP Q14145 EXPRESSION TAG SEQADV 6SP1 MET B 320 UNP Q14145 EXPRESSION TAG SEQADV 6SP1 ALA B 540 UNP Q14145 GLU 540 CONFLICT SEQADV 6SP1 ALA B 542 UNP Q14145 GLU 542 CONFLICT SEQRES 1 A 293 GLY SER HIS MET ALA PRO LYS VAL GLY ARG LEU ILE TYR SEQRES 2 A 293 THR ALA GLY GLY TYR PHE ARG GLN SER LEU SER TYR LEU SEQRES 3 A 293 GLU ALA TYR ASN PRO SER ASP GLY THR TRP LEU ARG LEU SEQRES 4 A 293 ALA ASP LEU GLN VAL PRO ARG SER GLY LEU ALA GLY CYS SEQRES 5 A 293 VAL VAL GLY GLY LEU LEU TYR ALA VAL GLY GLY ARG ASN SEQRES 6 A 293 ASN SER PRO ASP GLY ASN THR ASP SER SER ALA LEU ASP SEQRES 7 A 293 CYS TYR ASN PRO MET THR ASN GLN TRP SER PRO CYS ALA SEQRES 8 A 293 PRO MET SER VAL PRO ARG ASN ARG ILE GLY VAL GLY VAL SEQRES 9 A 293 ILE ASP GLY HIS ILE TYR ALA VAL GLY GLY SER HIS GLY SEQRES 10 A 293 CYS ILE HIS HIS ASN SER VAL GLU ARG TYR GLU PRO GLU SEQRES 11 A 293 ARG ASP GLU TRP HIS LEU VAL ALA PRO MET LEU THR ARG SEQRES 12 A 293 ARG ILE GLY VAL GLY VAL ALA VAL LEU ASN ARG LEU LEU SEQRES 13 A 293 TYR ALA VAL GLY GLY PHE ASP GLY THR ASN ARG LEU ASN SEQRES 14 A 293 SER ALA GLU CYS TYR TYR PRO GLU ARG ASN GLU TRP ARG SEQRES 15 A 293 MET ILE THR ALA MET ASN THR ILE ARG SER GLY ALA GLY SEQRES 16 A 293 VAL CYS VAL LEU HIS ASN CYS ILE TYR ALA ALA GLY GLY SEQRES 17 A 293 TYR ASP GLY GLN ASP GLN LEU ASN SER VAL GLU ARG TYR SEQRES 18 A 293 ASP VAL ALA THR ALA THR TRP THR PHE VAL ALA PRO MET SEQRES 19 A 293 LYS HIS ARG ARG SER ALA LEU GLY ILE THR VAL HIS GLN SEQRES 20 A 293 GLY ARG ILE TYR VAL LEU GLY GLY TYR ASP GLY HIS THR SEQRES 21 A 293 PHE LEU ASP SER VAL GLU CYS TYR ASP PRO ASP THR ASP SEQRES 22 A 293 THR TRP SER GLU VAL THR ARG MET THR SER GLY ARG SER SEQRES 23 A 293 GLY VAL GLY VAL ALA VAL THR SEQRES 1 B 293 GLY SER HIS MET ALA PRO LYS VAL GLY ARG LEU ILE TYR SEQRES 2 B 293 THR ALA GLY GLY TYR PHE ARG GLN SER LEU SER TYR LEU SEQRES 3 B 293 GLU ALA TYR ASN PRO SER ASP GLY THR TRP LEU ARG LEU SEQRES 4 B 293 ALA ASP LEU GLN VAL PRO ARG SER GLY LEU ALA GLY CYS SEQRES 5 B 293 VAL VAL GLY GLY LEU LEU TYR ALA VAL GLY GLY ARG ASN SEQRES 6 B 293 ASN SER PRO ASP GLY ASN THR ASP SER SER ALA LEU ASP SEQRES 7 B 293 CYS TYR ASN PRO MET THR ASN GLN TRP SER PRO CYS ALA SEQRES 8 B 293 PRO MET SER VAL PRO ARG ASN ARG ILE GLY VAL GLY VAL SEQRES 9 B 293 ILE ASP GLY HIS ILE TYR ALA VAL GLY GLY SER HIS GLY SEQRES 10 B 293 CYS ILE HIS HIS ASN SER VAL GLU ARG TYR GLU PRO GLU SEQRES 11 B 293 ARG ASP GLU TRP HIS LEU VAL ALA PRO MET LEU THR ARG SEQRES 12 B 293 ARG ILE GLY VAL GLY VAL ALA VAL LEU ASN ARG LEU LEU SEQRES 13 B 293 TYR ALA VAL GLY GLY PHE ASP GLY THR ASN ARG LEU ASN SEQRES 14 B 293 SER ALA GLU CYS TYR TYR PRO GLU ARG ASN GLU TRP ARG SEQRES 15 B 293 MET ILE THR ALA MET ASN THR ILE ARG SER GLY ALA GLY SEQRES 16 B 293 VAL CYS VAL LEU HIS ASN CYS ILE TYR ALA ALA GLY GLY SEQRES 17 B 293 TYR ASP GLY GLN ASP GLN LEU ASN SER VAL GLU ARG TYR SEQRES 18 B 293 ASP VAL ALA THR ALA THR TRP THR PHE VAL ALA PRO MET SEQRES 19 B 293 LYS HIS ARG ARG SER ALA LEU GLY ILE THR VAL HIS GLN SEQRES 20 B 293 GLY ARG ILE TYR VAL LEU GLY GLY TYR ASP GLY HIS THR SEQRES 21 B 293 PHE LEU ASP SER VAL GLU CYS TYR ASP PRO ASP THR ASP SEQRES 22 B 293 THR TRP SER GLU VAL THR ARG MET THR SER GLY ARG SER SEQRES 23 B 293 GLY VAL GLY VAL ALA VAL THR HET LQ8 A 701 37 HET ACT A 702 4 HET ACT A 703 4 HET ACT A 704 4 HET ACT A 705 4 HET ACT A 706 4 HET ACT A 707 4 HET ACT A 708 4 HET ACT A 709 4 HET ACT A 710 4 HET ACT B 701 4 HET ACT B 702 4 HET ACT B 703 4 HET ACT B 704 4 HET ACT B 705 4 HET ACT B 706 4 HETNAM LQ8 (1~{S},2~{R})-2-[[(1~{S})-1-[[1,3-BIS(OXIDANYLIDENE) HETNAM 2 LQ8 ISOINDOL-2-YL]METHYL]-5-(2-HYDROXYETHYLOXY)-3,4- HETNAM 3 LQ8 DIHYDRO-1~{H}-ISOQUINOLIN-2-YL]CARBONYL]CYCLOHEXANE-1- HETNAM 4 LQ8 CARBOXYLIC ACID HETNAM ACT ACETATE ION FORMUL 3 LQ8 C28 H30 N2 O7 FORMUL 4 ACT 15(C2 H3 O2 1-) FORMUL 19 HOH *173(H2 O) SHEET 1 AA1 4 THR A 351 ARG A 354 0 SHEET 2 AA1 4 LEU A 342 ASN A 346 -1 N ALA A 344 O LEU A 353 SHEET 3 AA1 4 LEU A 327 ALA A 331 -1 N ILE A 328 O TYR A 345 SHEET 4 AA1 4 GLY A 605 THR A 609 -1 O GLY A 605 N ALA A 331 SHEET 1 AA2 4 ALA A 366 VAL A 370 0 SHEET 2 AA2 4 LEU A 373 VAL A 377 -1 O TYR A 375 N CYS A 368 SHEET 3 AA2 4 LEU A 393 ASN A 397 -1 O TYR A 396 N LEU A 374 SHEET 4 AA2 4 GLN A 402 PRO A 405 -1 O SER A 404 N CYS A 395 SHEET 1 AA3 2 ARG A 380 ASN A 382 0 SHEET 2 AA3 2 ASN A 387 ASP A 389 -1 O THR A 388 N ASN A 381 SHEET 1 AA4 4 GLY A 417 ILE A 421 0 SHEET 2 AA4 4 HIS A 424 VAL A 428 -1 O TYR A 426 N GLY A 419 SHEET 3 AA4 4 VAL A 440 GLU A 444 -1 O GLU A 441 N ALA A 427 SHEET 4 AA4 4 GLU A 449 LEU A 452 -1 O HIS A 451 N ARG A 442 SHEET 1 AA5 2 SER A 431 HIS A 432 0 SHEET 2 AA5 2 ILE A 435 HIS A 436 -1 O ILE A 435 N HIS A 432 SHEET 1 AA6 4 GLY A 464 LEU A 468 0 SHEET 2 AA6 4 LEU A 471 PHE A 478 -1 O VAL A 475 N GLY A 464 SHEET 3 AA6 4 ARG A 483 TYR A 491 -1 O TYR A 490 N LEU A 472 SHEET 4 AA6 4 GLU A 496 MET A 499 -1 O ARG A 498 N CYS A 489 SHEET 1 AA7 4 GLY A 511 LEU A 515 0 SHEET 2 AA7 4 CYS A 518 TYR A 525 -1 O ALA A 522 N GLY A 511 SHEET 3 AA7 4 GLN A 530 ASP A 538 -1 O TYR A 537 N ILE A 519 SHEET 4 AA7 4 THR A 543 PHE A 546 -1 O THR A 545 N ARG A 536 SHEET 1 AA8 4 GLY A 558 VAL A 561 0 SHEET 2 AA8 4 ILE A 566 TYR A 572 -1 O LEU A 569 N GLY A 558 SHEET 3 AA8 4 PHE A 577 ASP A 585 -1 O LEU A 578 N GLY A 571 SHEET 4 AA8 4 THR A 590 ARG A 596 -1 O SER A 592 N CYS A 583 SHEET 1 AA9 4 THR B 351 ARG B 354 0 SHEET 2 AA9 4 LEU B 342 ASN B 346 -1 N ASN B 346 O THR B 351 SHEET 3 AA9 4 LEU B 327 ALA B 331 -1 N THR B 330 O GLU B 343 SHEET 4 AA9 4 GLY B 605 THR B 609 -1 O GLY B 605 N ALA B 331 SHEET 1 AB1 4 ALA B 366 VAL B 370 0 SHEET 2 AB1 4 LEU B 373 VAL B 377 -1 O TYR B 375 N CYS B 368 SHEET 3 AB1 4 LEU B 393 ASN B 397 -1 O TYR B 396 N LEU B 374 SHEET 4 AB1 4 GLN B 402 PRO B 405 -1 O SER B 404 N CYS B 395 SHEET 1 AB2 2 ARG B 380 ASN B 381 0 SHEET 2 AB2 2 THR B 388 ASP B 389 -1 O THR B 388 N ASN B 381 SHEET 1 AB3 4 GLY B 417 ILE B 421 0 SHEET 2 AB3 4 HIS B 424 VAL B 428 -1 O TYR B 426 N GLY B 419 SHEET 3 AB3 4 VAL B 440 TYR B 443 -1 O GLU B 441 N ALA B 427 SHEET 4 AB3 4 TRP B 450 LEU B 452 -1 O HIS B 451 N ARG B 442 SHEET 1 AB4 2 SER B 431 HIS B 432 0 SHEET 2 AB4 2 ILE B 435 HIS B 436 -1 O ILE B 435 N HIS B 432 SHEET 1 AB5 4 GLY B 464 LEU B 468 0 SHEET 2 AB5 4 LEU B 471 PHE B 478 -1 O VAL B 475 N GLY B 464 SHEET 3 AB5 4 ARG B 483 TYR B 491 -1 O LEU B 484 N GLY B 477 SHEET 4 AB5 4 GLU B 496 MET B 499 -1 O ARG B 498 N CYS B 489 SHEET 1 AB6 4 GLY B 511 VAL B 514 0 SHEET 2 AB6 4 CYS B 518 ALA B 522 -1 O ALA B 522 N GLY B 511 SHEET 3 AB6 4 VAL B 534 ASP B 538 -1 O TYR B 537 N ILE B 519 SHEET 4 AB6 4 THR B 543 PHE B 546 -1 O THR B 545 N ARG B 536 SHEET 1 AB7 4 GLY B 558 VAL B 561 0 SHEET 2 AB7 4 ILE B 566 TYR B 572 -1 O TYR B 567 N THR B 560 SHEET 3 AB7 4 PHE B 577 ASP B 585 -1 O LEU B 578 N GLY B 571 SHEET 4 AB7 4 THR B 590 ARG B 596 -1 O SER B 592 N CYS B 583 SSBOND 1 CYS A 434 CYS B 434 1555 1555 2.03 SITE 1 AC1 17 TYR A 334 GLY A 364 LEU A 365 ARG A 380 SITE 2 AC1 17 ASN A 414 ARG A 415 GLY A 462 GLY A 509 SITE 3 AC1 17 ALA A 556 TYR A 572 SER A 602 GLY A 603 SITE 4 AC1 17 VAL A 604 ACT A 703 HOH A 801 HOH A 815 SITE 5 AC1 17 HOH A 822 SITE 1 AC2 5 ARG A 415 PHE A 478 ARG A 483 SER A 508 SITE 2 AC2 5 ACT A 703 SITE 1 AC3 6 TYR A 525 GLN A 530 SER A 555 TYR A 572 SITE 2 AC3 6 LQ8 A 701 ACT A 702 SITE 1 AC4 4 ARG A 380 GLY A 433 GLY B 433 CYS B 434 SITE 1 AC5 3 ILE A 435 HIS A 436 ARG A 459 SITE 1 AC6 4 VAL A 411 HIS A 432 ILE A 435 HIS A 437 SITE 1 AC7 5 ILE A 421 ASP A 422 HIS A 424 TYR A 426 SITE 2 AC7 5 ARG A 442 SITE 1 AC8 3 MET A 399 TYR A 473 TYR A 537 SITE 1 AC9 3 LEU A 339 SER A 340 TYR A 341 SITE 1 AD1 5 LEU A 471 TYR A 491 PRO A 492 GLU A 493 SITE 2 AD1 5 ARG A 494 SITE 1 AD2 2 ILE B 435 HIS B 436 SITE 1 AD3 4 TYR B 491 PRO B 492 GLU B 493 ARG B 494 SITE 1 AD4 4 MET B 399 TYR B 473 TYR B 491 TYR B 537 SITE 1 AD5 5 VAL B 411 HIS B 432 ILE B 435 HIS B 437 SITE 2 AD5 5 ACT B 705 SITE 1 AD6 5 VAL B 411 HIS B 437 SER B 439 ACT B 704 SITE 2 AD6 5 HOH B 849 SITE 1 AD7 6 ASP A 385 GLY A 386 ASN A 387 PHE B 478 SITE 2 AD7 6 ARG B 483 SER B 508 CRYST1 76.164 76.387 204.839 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013130 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013091 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004882 0.00000